======= SMYD2 ======= == Gene Information == * **Official Symbol**: SMYD2 * **Official Name**: SET and MYND domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56950|56950]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NRG4|Q9NRG4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SMYD2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMYD2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610663|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Protein-lysine N-methyltransferase that methylates both histones and non-histone proteins, including p53/TP53 and RB1. Specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). Shows even higher methyltransferase activity on p53/TP53. Monomethylates 'Lys-370' of p53/TP53, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity of p53/TP53. Monomethylates RB1 at 'Lys-860'. {ECO:0000269|PubMed:17108971, ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:18065756, ECO:0000269|PubMed:20870719, ECO:0000269|PubMed:21782458, ECO:0000269|PubMed:21880715}. |SET| |zf-MYND| |lysine N-methyltransferase activity| |histone H3-K36 methylation| |histone methyltransferase activity (H3-K36 specific)| |peptidyl-lysine monomethylation| |peptidyl-lysine dimethylation| |protein-lysine N-methyltransferase activity| |RNA polymerase II complex binding| |regulation of DNA damage response, signal transduction by p53 class mediator| |p53 binding| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |protein methylation| |protein alkylation| |regulation of signal transduction by p53 class mediator| |regulation of response to DNA damage stimulus| |macromolecule methylation| |methylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |heart development| |negative regulation of cell population proliferation| |chromatin organization| |regulation of cellular response to stress| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |peptidyl-amino acid modification| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |regulation of cell population proliferation| |negative regulation of gene expression| |regulation of intracellular signal transduction| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18089 * **Expression level (log2 read counts)**: 5.71 {{:chemogenomics:nalm6 dist.png?nolink |}}